Vol 2009, No 2 (2009)

Table of Contents

Research & Development

Dyax and Biogen Idec Expand Drug Discovery Deal Abstract html
Taskin Ahmed

Licensing

Merck Serono Signs Multiple Sclerosis Deal with Ambrx Abstract html
Taskin Ahmed
Shire to Enter European ADHD Market Abstract html
Taskin Ahmed
Novartis Pays US$75 M for Portola's Anticoagulant Abstract html
Taskin Ahmed
GSK Licenses Idenix’s HIV Drug Abstract html
Taskin Ahmed

Mergers & Acquisitions

Merck Makes Further Inroads into Biologicals Abstract html
Taskin Ahmed
Lundbeck to Buy US-based Ovation Abstract html
Taskin Ahmed

Editorial

Who’s next for a mega merger? Abstract html
Taskin Ahmed


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.